Gain of 11q13.2 was determined to be an independent prognostic factor for predicting poor outcome, and amplification of CPT1A in 11q13.2 was correlated with shorter overall survival in ESCC. The gene discussed is CPT1A; the disease is esophageal squamous cell carcinoma.